Guiding the way forward to bring transformative treatments to
people with rare disease
Backed by decades of expertise
across drug development, commercialization, and genetic medicine.
across drug development, commercialization, and genetic medicine.
Adrian Chaisson
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer